Pharmaceutical General Sector
Pharma Futures is an investor-led dialogue that explores how to better align corporate profitability with improved access to innovative and affordable healthcare. It has run from 2003-2008 in three distinct phases
1 The Pharmaceutical Sector: A Long-Term Value Outlook
A scenario-planning exercise undertaken by the pharmaceutical industry and its investors, Pharma Futures 1 identified three plausible futures, each of which represented significant change for the industry
2 Prescription for Long-Term Value
Pharma Futures 2 moved from hypothetical futures to explore real-world challenges, concluding that three trends will determine the industry’s future value: R&D Landscape, Value for Money and the Emerging Markets.
3 Emerging Opportunities
Pharma Futures 3 explores the links between sustainable pharmaceutical business models and improved health outcomes in middle-income markets, including China, India and Brazil.
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceutical Research and Manufacturers of America (PhRMA), founded in 1958, is an trade group representing the pharmaceutical research and biotechnology companies in the United States. PhRMA's mission is advocacy for public policies that encourage the discovery of new medicines for patients by pharmaceutical and biotechnology research companies. PhRMA's current CEO is former congressman Billy Tauzin.